42 U.S.C. 300b-5: Sickle cell disease and other heritable blood disorders research, surveillance, prevention, and treatment

2018

• Pub. L. 115–327, §3(b), transferred section 712(c) of Pub. L. 108–357 to this section and redesignated it as subsec. (b). See Codification note above. Law text · (b)
• Pub. L. 115–327, §3(a)(1), substituted "sickle cell disease" for "Sickle Cell Disease" wherever appearing. Law text · (b)
• Pub. L. 115–327, §3(a)(2), substituted "shall continue efforts, including by awarding grants, to develop or establish mechanisms to improve the treatment of sickle cell disease, and to improve the prevention and treatment of complications of sickle cell disease, in populations wi… Law text · (b)
• Pub. L. 115–327, §3(a)(3), substituted "Geographic diversity" for "Grant award requirements" in heading, struck out cl. (i) designation and heading before "The Administrator shall", and struck out cl. (ii) which related to priority in awarding grants. Law text · (b)
• Pub. L. 115–327, §3(a)(4), added subpar. (E). Law text · (b)
• Pub. L. 115–327, §3(a)(5), substituted "$4,455,000 for each of fiscal years 2019 through 2023" for "$10,000,000 for each of fiscal years 2005 through 2009". Law text · (b)